Pharmacyte Biotech Inc (PMCB)

Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-07-31	2026-04-30	2026-01-31	2025-10-31	2025-07-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	59.91%1.01	2.51	2.12	1.38	0.85
Research and Development	3.14%0.06	0.06	0.09	0.14	0.10
Operating Income/Loss	59.91%-1.01	-2.51	-2.12	-1.38	-0.85
Nonoperating Income/Loss	116.48%-4.07	-1.88	2.86	-6.04	-7.51
Income Tax Expense/Benefit	-	-	-	-	-
	15.65%-5.08	-4.39	0.75	-7.42	-8.36
Attributable To Parent	15.65%-5.08	-4.39	0.75	-7.42	-8.36
Available To Common Stockholders, Basic	18.72%-5.79	-4.87	-1.56	-8.42	-8.36
Basic Average Shares	10.74	-	9.26	6.80	6.80
Diluted Average Shares	10.74	-	9.26	6.80	6.80
Basic Earnings Per Share	-0.54	-	-0.17	-1.24	-1.23
Diluted Earnings Per Share	-0.54	-	-0.17	-1.24	-1.23
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	18.72%-5.79	-4.87	-1.56	-8.42	-8.36